So, you want to look for biomarkers (Introduction to the special biomarkers issue)

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The burgeoning field of proteomics plays a powerful and relevant role in the discovery of biomarkers, which are biometric measurements that convey information about the biological condition of the subject being tested. Biomarkers have changed the manner in which we diagnose disease, monitor the effect of therapy, classify disease, detect toxicity, and develop new drugs. The central part that proteins command in both disease etiology and treatment make them prime biomarker candidates. Indeed, the majority of clinical tests in use today measure proteins. This perspective introduces the Journal of Proteome Research Special Issue on Proteomics and Biomarkers. It outlines the major applications of biomarkers, discusses the basics of statistically assessing them and considers the crucial choice of sample type. Central considerations of biomarker discovery and validation, particularly with respect to their intended clinical and research applications, are highlighted.

Original languageEnglish (US)
Pages (from-to)1053-1059
Number of pages7
JournalJournal of Proteome Research
Volume4
Issue number4
DOIs
StatePublished - Jul 2005
Externally publishedYes

Fingerprint

Biomarkers
Proteomics
Proteome
Biometrics
Research
Toxicity
Proteins
Pharmaceutical Preparations

Keywords

  • Biomarkers
  • Clinical proteomics
  • Drugs
  • Sensitivity
  • Specificity
  • Statistical considerations
  • Toxicity

ASJC Scopus subject areas

  • Genetics
  • Biotechnology
  • Biochemistry

Cite this

So, you want to look for biomarkers (Introduction to the special biomarkers issue). / LaBaer, Joshua.

In: Journal of Proteome Research, Vol. 4, No. 4, 07.2005, p. 1053-1059.

Research output: Contribution to journalArticle

@article{066dd82b1ec74917a169abd5eeeb3be3,
title = "So, you want to look for biomarkers (Introduction to the special biomarkers issue)",
abstract = "The burgeoning field of proteomics plays a powerful and relevant role in the discovery of biomarkers, which are biometric measurements that convey information about the biological condition of the subject being tested. Biomarkers have changed the manner in which we diagnose disease, monitor the effect of therapy, classify disease, detect toxicity, and develop new drugs. The central part that proteins command in both disease etiology and treatment make them prime biomarker candidates. Indeed, the majority of clinical tests in use today measure proteins. This perspective introduces the Journal of Proteome Research Special Issue on Proteomics and Biomarkers. It outlines the major applications of biomarkers, discusses the basics of statistically assessing them and considers the crucial choice of sample type. Central considerations of biomarker discovery and validation, particularly with respect to their intended clinical and research applications, are highlighted.",
keywords = "Biomarkers, Clinical proteomics, Drugs, Sensitivity, Specificity, Statistical considerations, Toxicity",
author = "Joshua LaBaer",
year = "2005",
month = "7",
doi = "10.1021/pr0501259",
language = "English (US)",
volume = "4",
pages = "1053--1059",
journal = "Journal of Proteome Research",
issn = "1535-3893",
publisher = "American Chemical Society",
number = "4",

}

TY - JOUR

T1 - So, you want to look for biomarkers (Introduction to the special biomarkers issue)

AU - LaBaer, Joshua

PY - 2005/7

Y1 - 2005/7

N2 - The burgeoning field of proteomics plays a powerful and relevant role in the discovery of biomarkers, which are biometric measurements that convey information about the biological condition of the subject being tested. Biomarkers have changed the manner in which we diagnose disease, monitor the effect of therapy, classify disease, detect toxicity, and develop new drugs. The central part that proteins command in both disease etiology and treatment make them prime biomarker candidates. Indeed, the majority of clinical tests in use today measure proteins. This perspective introduces the Journal of Proteome Research Special Issue on Proteomics and Biomarkers. It outlines the major applications of biomarkers, discusses the basics of statistically assessing them and considers the crucial choice of sample type. Central considerations of biomarker discovery and validation, particularly with respect to their intended clinical and research applications, are highlighted.

AB - The burgeoning field of proteomics plays a powerful and relevant role in the discovery of biomarkers, which are biometric measurements that convey information about the biological condition of the subject being tested. Biomarkers have changed the manner in which we diagnose disease, monitor the effect of therapy, classify disease, detect toxicity, and develop new drugs. The central part that proteins command in both disease etiology and treatment make them prime biomarker candidates. Indeed, the majority of clinical tests in use today measure proteins. This perspective introduces the Journal of Proteome Research Special Issue on Proteomics and Biomarkers. It outlines the major applications of biomarkers, discusses the basics of statistically assessing them and considers the crucial choice of sample type. Central considerations of biomarker discovery and validation, particularly with respect to their intended clinical and research applications, are highlighted.

KW - Biomarkers

KW - Clinical proteomics

KW - Drugs

KW - Sensitivity

KW - Specificity

KW - Statistical considerations

KW - Toxicity

UR - http://www.scopus.com/inward/record.url?scp=23944439913&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23944439913&partnerID=8YFLogxK

U2 - 10.1021/pr0501259

DO - 10.1021/pr0501259

M3 - Article

VL - 4

SP - 1053

EP - 1059

JO - Journal of Proteome Research

JF - Journal of Proteome Research

SN - 1535-3893

IS - 4

ER -